ID: ALA5205517

Max Phase: Preclinical

Molecular Formula: C13H12N6O4

Molecular Weight: 316.28

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc(-n2cc(CO)nn2)cc(-n2cc(CO)nn2)c1

Standard InChI:  InChI=1S/C13H12N6O4/c20-6-9-4-18(16-14-9)11-1-8(13(22)23)2-12(3-11)19-5-10(7-21)15-17-19/h1-5,20-21H,6-7H2,(H,22,23)

Standard InChI Key:  CXHMHOMEELOFAT-UHFFFAOYSA-N

Associated Targets(non-human)

Ribonuclease pancreatic 177 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 316.28Molecular Weight (Monoisotopic): 316.0920AlogP: -0.47#Rotatable Bonds: 5
Polar Surface Area: 139.18Molecular Species: ACIDHBA: 9HBD: 3
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.78CX Basic pKa: CX LogP: -0.33CX LogD: -3.60
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.57Np Likeness Score: -0.87

References

1. Das A, Dasgupta S, Pathak T..  (2022)  Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors.,  71  [PMID:35944385] [10.1016/j.bmc.2022.116888]

Source